Acute Care Volume 22, Issue 8

Medication Safety Alert! April 20, 2017

In this week's issue:

Featured article

The latest issue of ISMP’s QuarterWatch™ provides a review of drug safety issues reflected in adverse drug events reported to the US Food and Drug Administration (FDA) during the third quarter (Q3) of 2016 and during the previous 12 months. In this report, we examine depression and suicidal thoughts or behaviors as an adverse effect of certain drugs, with a focus on three newer medications not intended to treat psychiatric disorders:

  • Roflumilast (DALIRESP), used to reduce exacerbations in patients with severe chronic obstructive pulmonary disease (COPD)
  • Apremilast (OTEZLA), used to treat...

Access this Newsletter

Purchasing Options

Purchase access to this individual issue

Purchase a year's access to this bi-weekly publication (25 issues)